The Affiliated Hospital of Jiangxi University of Traditional Chinese Medicine, Nanchang.
Central Health Center of Juncun Township, Xingguo County.
Medicine (Baltimore). 2021 Mar 12;100(10):e24994. doi: 10.1097/MD.0000000000024994.
Chronic cholecystitis is a common chronic disease in clinical practice. The incidence of chronic cholecystitis is gradually increasing due to changes in eating habits and even if acute infections aren't treated in time, it can cause serious complications, continue to plague people's daily life and become an economic burden to society. Currently, the curative effect of chronic cholecystitis under the control of western medicine is still lacking and there are adverse reactions. However, based on current clinical controlled trials acupuncture therapy for chronic cholecystitis has gradually become a complementary treatment. Therefore, this systematic review aims to explore the safety and feasibility of acupuncture therapy in the treatment of chronic cholecystitis.
We will search the following databases: Medline, PubMed, Cochrane Database of Systematic Reviews, Embase, Chinese Biomedical Literatures Database, China National Knowledge Infrastructure, Wang Fang Database, Chinese Scientific Journal Database from inception to February 2021 without any language restriction. At the same time, relevant literature will be searched manually. The main search terms include: "Acupuncture," "Cholecystitis." Data entry will be completed by 2 researchers separately. After entry, cross-checking will be performed to ensure the authenticity of the information. The main outcome criteria include: including the total effective rate of the patient; the traditional Chinese medicine symptom score of the patient includes: abdominal pain, tenderness in the right upper abdomen, and so on; secondary outcome criteria include: gallbladder contraction function and gallbladder thickness, VAS scores, recurrence rate, adverse reactions; use Cochrane risk bias assessment to evaluate and score the included randomized controlled trial; meta-analysis will be performed using RevMan 5.4.0 software. The heterogeneity test is based on the thresholds of P and I2, In order to use solid or random effects models.
This systematic review only evaluates the safety and limitations of acupuncture therapy in the treatment of chronic cholecystitis. We will report the full text in the near future.
This study will explore the safety and limitations of acupuncture therapy in the treatment of chronic cholecystitis, so that acupuncture therapy will be more widely used clinically.
INPLASY202120020.
慢性胆囊炎是临床常见的慢性疾病，由于饮食习惯的改变，其发病率逐渐增高，甚至急性感染若不及时治疗，也可引发严重并发症，持续困扰人们的日常生活，成为社会的经济负担。目前，在西医的控制下，慢性胆囊炎的疗效仍不理想，且有不良反应。然而，基于目前的临床对照试验，针刺疗法治疗慢性胆囊炎已逐渐成为一种辅助治疗方法。因此，本系统评价旨在探讨针刺疗法治疗慢性胆囊炎的安全性和可行性。
我们将检索以下数据库：Medline、PubMed、Cochrane 系统评价数据库、Embase、中国生物医学文献数据库、中国知网、万方数据库、中国科学引文数据库，检索时间均从建库至 2021 年 2 月，无语言限制。同时，还将手动检索相关文献。主要检索词包括：“针刺”、“胆囊炎”。由 2 名研究人员分别完成数据录入，录入后进行交叉核对，以确保信息的真实性。主要结局指标包括：患者的总有效率；患者的中医症状评分，包括腹痛、右上腹压痛等；次要结局指标包括：胆囊收缩功能、胆囊厚度、VAS 评分、复发率、不良反应；采用 Cochrane 风险偏倚评估工具对纳入的随机对照试验进行评估和评分；使用 RevMan 5.4.0 软件进行荟萃分析。异质性检验基于 P 值和 I²阈值，采用固定或随机效应模型。
本系统评价仅评估针刺疗法治疗慢性胆囊炎的安全性和局限性，我们将在不久的将来报告全文。
本研究将探讨针刺疗法治疗慢性胆囊炎的安全性和局限性，以便针刺疗法在临床上得到更广泛的应用。
INPLASY202120020。
